A new contrast agent for MRI

A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used gadolinium agents have been found to produce adverse effects in patients with impaired kidney function.